Literature DB >> 2816401

[Cytotoxic effects of changrolin, lidocaine and amiodarone on ultrastructure of cultured rat beating cardiac myocytes].

Y Z Yang, X Y Yang, Q Guo, P Y Jin, H Z Chen, J Y Shen, B Z Pen, Z X Gong, W Z Chen.   

Abstract

Ultrastructural and morphological alterations of cultured rat beating cardiac myocytes treated with changrolin (CRL), lidocaine (Lid), and amiodarone (Ami) were studied. After the cultures were treated with CRL 100 micrograms/ml for 24 h, the beating of the myocytes stopped, the configuration and fine structure were destroyed, while the nuclei showed pyknotic deformation and reduced in size. The membrane and structures of mitochondria were disrupted and myofibrils fragmented and disrupted. In addition, a lot of vacuoles with characteristic dense particles were found in the cytoplasm. Similar alterations were seen when Lid 1000 micrograms/ml and Ami 50 micrograms/ml were added to the cultures. Normal beating networks of myocytes were examined under inverted microscopy after the cultured cells were treated with CRL 25 micrograms/ml, Lid 250 micrograms/ml or Ami 6.25 micrograms/ml. The ultrastructure of some regions of the myocytes showed very slight damage. The results indicated that the dosage of CRL and Lid generally used in anti-arrhythmic therapy basically exerted no harm to myocytes. However, caution should be taken when Ami was given intravenously, since its effective serum concentration was close to the dosage which could cause slight damage to the ultrastructure of cultured cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816401

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN: 0253-9756


  1 in total

1.  Class III antiarrhythmic drugs amiodarone and dronedarone impair KIR 2.1 backward trafficking.

Authors:  Yuan Ji; Hiroki Takanari; Muge Qile; Lukas Nalos; Marien J C Houtman; Fee L Romunde; Raimond Heukers; Paul M P van Bergen En Henegouwen; Marc A Vos; Marcel A G van der Heyden
Journal:  J Cell Mol Med       Date:  2017-04-19       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.